Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

3 Jul 2008 07:00

RNS Number : 1776Y
Heath(Samuel) & Sons PLC
03 July 2008
 



HEATH (Samuel) & SONS PLC

3RD JULY 2008

PRELIMINARY RESULTS FOR THE YEAR ENDED 31ST MARCH 2008

CHAIRMAN'S STATEMENT

The results for the year to 31st March 2008 were well down on the previous one, but not quite as much as anticipated. Turnover fell 4%, and operating profit was down from £1,469,000 to £1,182,000.

In March, non-Executive Director Charles Flint died. His keen and probing mind and wise counsel will be very much missed by his colleagues.

Roger Jeynes will also be relinquishing his directorship of the Management Board, as he moves to much shorter working hours. He has been responsible for the development of two world patented and unique products, the Perkomatic and later the Perko-Powermatic door closers. Unbeknown to him, we did try to obtain recognition for this, and his work in Europe with C.E.N., on a more countrywide basis. We were told that he was almost certainly of the wrong ethnic background for such an award. What strange times we live in, when you might consider engineering innovation to be vital to this country. These remarks are, in no way, meant to show any lack of appreciation of the skills and hard work of the wide variety of people, with whom I have had the privilege to work, for over fifty years.

Your Directors believe that a purchase of the Company's shares at the right price level could benefit the Company, and thereby its shareholders. Accordingly, your Directors are seeking your approval for the purchase of up to 15% of the issued share capital, 380,298 shares, between Annual General Meetings. 

The change in the product mix, which was foreseen for the previous year, is continuing. We have commodity prices through the roof, and by any standards difficult trading conditions practically everywhere. This is combined with the reluctance of the market to accept higher prices against any logical rationale. All this forces me to anticipate a further significant fall in profits for the coming year.

However, on the basis of the Company's strong balance sheet, your Directors are recommending a same again final dividend of 12.5 pence per share.

CONSOLIDATED INCOME STATEMENT

Total

 2008

Total

 2007

£000

£000

Continuing operations

Revenue

12,191

12,712

Cost of sales

5,355

5,702

Gross profit

6,836

7,010

Distribution costs

384

411

Administrative expenses

5,270

5,130

Operating profit:

Net of contributions to pension deficit

672

964

Contributions to pension deficit 

510

505

1,182

1,469

Finance income

778

787

Finance costs

568

523

210

264

Profit before taxation

1,392

1,733

Taxation 

345

349

Profit for the year

1,047

1,384

Basic and diluted earnings per ordinary share 

41.3 p

54.5 p

  

CONSOLIDATED BALANCE SHEET

2008

£000

2007

£000

Non current assets

Property, plant and equipment

2,934

3,201

Deferred tax asset

101

235

3,035

3,436

Current assets

Inventories

2,787

2,645

Trade and other receivables

2,166

2,135

Cash and cash equivalents

1,728

1,901

Total current assets

6,681

Total assets

9,716

10,117

Current liabilities

Trade and other payables 

986

1,183

Current tax payable

213

245

Total current liabilities

1,199

1,428

Non current liabilities

Pension scheme deficit

360

783

Deferred tax liability

252

292

Total non current liabilities

612

1,075

Total liabilities

1,811

2,503

Net assets

7,905

7,614

Equity

Called up share capital

254

254

Capital redemption reserve

109

109

Retained earnings

7,542

7,251

Equity shareholders' funds

7,905

7,614

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Share

capital

Capital redemption reserve

Retained earnings

Total

equity

£000

£000

£000

£000

Balance at 31st March 2006

255

108

6,733

7,096

Actuarial losses on defined benefit pension scheme 

-

-

 (301)

 (301)

Deferred taxation on items taken to equity

-

-

90

90

Net income recognised directly in equity

-

-

(211)

(211)

Profit for the period

-

-

1,384

1,384

Total recognised income and expense for the period

-

-

1,173

1,173

Purchase of own shares

(1)

1

-

-

Premium on purchase of own shares

-

-

(57)

(57)

Equity dividends paid

-

-

(598)

(598)

Balance at 31st March 2007

254

109

7,251

7,614

Actuarial loss on defined benefit pension scheme 

-

-

(200)

(200)

Deferred taxation on items taken to equity

-

-

40

40

Net loss recognised directly in equity

-

-

(160)

(160)

Profit for the period

-

-

1,047

1,047

Total recognised income and expense for the period

-

-

887

887

Equity dividends paid

-

-

(596)

(596)

Balance at 31st March 2008

254

109

7,542

7,905

  CONSOLIDATED AND PARENT CASH FLOW STATEMENTS 

Note

2008

2007

£000

£000

Net cash inflow from operating activities

6

519

205

Cashflow from investing activities

Purchases of property, plant and equipment

(226)

(490)

Proceeds from sale of property, plant and equipment

33

51

Interest received

97

99

Net cash outflow from investing activities

(96)

(340)

Net cash outflow from financing activities

Purchase of own shares

-

(57)

Equity dividends paid

(596)

(598)

Net cash outflow from financing activities

(596)

(655)

Decrease in cash and cash equivalents

(173)

(790)

Cash and cash equivalents at beginning of period

1,901

2,691

Cash and cash equivalents at end of period

1,728

1,901

 

1. Adoption of new and revised Standards

In the current year, the Group has adopted all of the new and revised Standards and Interpretations issued by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee (IFRIC) of the IASB that are relevant to its operations and effective for accounting periods beginning on 1st April 2007. The adoption of the following IFRSs has not impacted the audited financial statements other than for disclosure.

IFRS 3 - Business Combinations 

IFRS 7 - Financial Instruments - disclosure

IAS 1 - Presentation of Financial Statements

IAS 27 - Consolidated and Separate Financial Statements

At the date of authorisation of these financial statements, the following Standard which has not been applied in these financial statements was in issue but not yet effective:

IFRS 8 - Operating Segments

The other Standards and Interpretations are not expected to have any significant impact on the Group's financial statement, in their periods of initial application, except for the additional disclosures on operating segments when the relevant standard comes into effect for periods commencing on or after 1st January 2009.

 

2. Accounting policies

Basis of accounting

The financial statements, upon which this financial information is based, have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRS) for the first time. The disclosures required by IFRS 1 concerning the transition from UK GAAP to IFRS are given in note 7.

The financial statements have been prepared under the historical cost basis.

 

3. Critical accounting and key sources of estimation

Critical judgements in applying the entity's accounting policies

In the process of applying the entity's accounting policies, which are described above, the directors have made the following judgements that have the most significant effect on the amounts recognised in the financial statements.

Income taxes

The Group is subject to income taxes in the United Kingdom. Judgment is required in determining the provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognises liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

The recoverable amounts of the Group's deferred tax assets have been determined based on the Board's estimates of future taxable profits and income and tax rates. 

Key sources of estimation uncertainty

The key assumptions concerning the future, and other key sources of estimation uncertainty at the balance sheet date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.

Retirement benefit scheme deficit

The valuation of expected returns on assets and the present value of the liabilities of the scheme are determined by assumptions and estimates made by the directors based on the current information to hand. Therefore amounts are open to fluctuations in the future due to unforeseen changes or additional factors that come to light following the year end.

 4. Dividends

 

2008

2007

£ 000

£ 000

Final dividend for the year ended 31st March 2007 of 12.5 pence per share (2006: 12.5 pence per share)

317

319

Interim dividend for the year ended 31st March 2008 of 11.0 pence per share (2007: 11.0 pence per share)

279

279

596

598

In addition to the dividends paid during the year the directors are recommending a final dividend for 2008 of 12.5 pence per share amounting to £317,000. The proposed final dividend is subject to approval at the Annual General Meeting (see note 8) and has not been included as a liability in these accounts.

 

5. Earnings per share

 

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £1,047,000 (2007: £1,384,000) by the average number of ordinary shares in issue during the year being 2,535,000 (2007: 2,538,700). The number of shares used in the calculation is the same for both basic and diluted earnings.

 

6. Notes to the cash flow statement

2008

2007

£000

£000

Results from operating activities

1,182

1,469

Depreciation of property, plant and equipment

468

450

Gain on disposal of property, plant and equipment

(8)

(2)

Operating cash flows before movements in working capital

1,642

1,917

Increase in inventories

(142)

(454)

(Increase)/decrease in receivables

(31)

19

Decrease in payables

(197)

(572)

Pension contributions

(510)

(505)

Cash generated by operations

762

405

Income tax paid

(243)

(200)

Net cash flow from operating activities

519

205

Cash and cash equivalents (which are presented as a single class of assets on the face of the balance sheet) comprise cash at bank and other short-term highly liquid investments with a maturity of three months or less.

 7. Explanation of transition to IFRS

The Group has applied IFRS 1 "First Time Adoption of International Financial Reporting Standards" as a starting point for reporting under IFRS. The Group's date of transition is 1st April 2006 and comparative information has been restated to reflect in the Group's adoption of IFRS except where otherwise required or permitted by IFRS 1.

IFRS 1 requires an entity to comply with each IFRS and IAS effective at the reporting date for its first financial statements prepared under IFRS. As a general rule, IFRS 1 requires such standards to be applied retrospectively. However, the standard allows several optional exemptions from full retrospective application.

The Group has elected to take advantage of the following exemption. Business combinations made prior to 1st April 2006 will not be accounted for under IFRS 3 "Business Combinations" and as such the value of goodwill in the balance sheet at that date will be the same amount under IFRS as that recorded in the UK GAAP financial statements, subject to the completion of an annual impairment review.

No adjustments were required in order for the Group to comply with IFRS. 

 

8. Annual General Meeting

The Annual General Meeting has been fixed for Friday 15th August 2008 at 12 noon. The final Ordinary Share dividend of 12.5 pence will be declared payable on 22nd August 2008 to ordinary shareholders registered at close of business on 25th July 2008.

 

9. Section 240 statement 

The financial information set out above does not constitute the company's statutory accounts for the years ended 31st March 2008 or 2007. Statutory accounts for 2007, which were prepared under UK GAAP, have been delivered to the Registrar of Companies, and those for 2008 prepared under IFRS, will be delivered in due course. The auditors have reported on the 2007 accounts; their report was unqualified, did not include references to any matters by way of emphasis without qualifying their report and did not contain statements under Section 237 (2) or (3) of the Companies Act 1985. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSFFIESASESW
Date   Source Headline
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.